• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤治疗中的活检技术。

Biopsy technique in the treatment of osteosarcoma.

作者信息

Cara del Rosal J A, Cañadell J

机构信息

Department of Orthopaedic Surgery, University Clinic, Faculty of Medicine, University of Navarre, Pamplona, Spain.

出版信息

Int Orthop. 1994;18(6):375-8. doi: 10.1007/BF00187086.

DOI:10.1007/BF00187086
PMID:7698871
Abstract

Seventy-eight consecutive patients with stage IIB osteosarcoma of the appendicular skeleton, treated between 1982 and 1992, were studied to determine whether the technique of biopsy affected the prognosis for long term survival. The risk of local recurrence was significant (p < 0.02) after open biopsy, as was the poor response to chemotherapy (p < 0.05) after percutaneous biopsy. We recommend percutaneous biopsy, if possible, when an osteosarcoma is suspected.

摘要

对1982年至1992年间接受治疗的78例连续性四肢骨骼IIB期骨肉瘤患者进行研究,以确定活检技术是否会影响长期生存预后。切开活检后局部复发风险显著(p<0.02),经皮活检后对化疗反应不佳(p<0.05)。如果怀疑骨肉瘤,我们建议尽可能采用经皮活检。

相似文献

1
Biopsy technique in the treatment of osteosarcoma.骨肉瘤治疗中的活检技术。
Int Orthop. 1994;18(6):375-8. doi: 10.1007/BF00187086.
2
Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.化疗后肿瘤体积增加的截断值评估对 IIB 期骨肉瘤后续肿瘤事件的预测价值。
J Surg Oncol. 2014 Mar;109(3):275-9. doi: 10.1002/jso.23496. Epub 2013 Nov 14.
3
Prognosis of osteosarcoma treated by limb-salvage surgery: the ten-year intergroup study in Japan.
Jpn J Clin Oncol. 1992 Oct;22(5):347-53.
4
Osteosarcoma. Specimen management following primary chemotherapy.
Hematol Oncol Clin North Am. 1995 Aug;9(4):841-67.
5
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).综合治疗后骨肉瘤复发:对骨肉瘤协作研究组(COSS)中未经挑选患者的分析。
J Clin Oncol. 2005 Jan 20;23(3):559-68. doi: 10.1200/JCO.2005.04.063.
6
Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.局部复发对接受新辅助化疗的肢体骨肉瘤患者生存的影响:一家机构对44例患者的经验。
Cancer. 2006 Jun 15;106(12):2701-6. doi: 10.1002/cncr.21937.
7
Osteosarcomas of flat bones in adolescents and adults.青少年和成人扁平骨骨肉瘤
Cancer. 2000 Jan 15;88(2):324-32. doi: 10.1002/(sici)1097-0142(20000115)88:2<324::aid-cncr12>3.0.co;2-e.
8
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.P-糖蛋白和临床病理因素在肢体高级别骨肉瘤新治疗策略中的价值
J Clin Oncol. 2003 Feb 1;21(3):536-42. doi: 10.1200/JCO.2003.03.144.
9
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.肢体骨肉瘤的辅助化疗和新辅助化疗:意大利里佐利研究所27年的经验
Eur J Cancer. 2005 Dec;41(18):2836-45. doi: 10.1016/j.ejca.2005.08.026. Epub 2005 Nov 17.
10
Tumor necrosis and prognosis in osteosarcoma.骨肉瘤中的肿瘤坏死与预后
Acta Orthop Scand Suppl. 1997 Feb;273:126-9. doi: 10.1080/17453674.1997.11744717.

引用本文的文献

1
Osteosarcoma: a review of current and future therapeutic approaches.骨肉瘤:当前和未来治疗方法的综述。
Biomed Eng Online. 2021 Mar 2;20(1):24. doi: 10.1186/s12938-021-00860-0.
2
Safety and Accuracy of Core Needle Biopsy for Soft Tissue Masses in an Ambulatory Setting.门诊环境下软组织肿块粗针活检的安全性与准确性
Sarcoma. 2018 Jun 12;2018:1657864. doi: 10.1155/2018/1657864. eCollection 2018.

本文引用的文献

1
A system for the surgical staging of musculoskeletal sarcoma.一种用于肌肉骨骼肉瘤手术分期的系统。
Clin Orthop Relat Res. 1980 Nov-Dec(153):106-20.
2
The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.原发性恶性骨与软组织肿瘤患者活检的风险
J Bone Joint Surg Am. 1982 Oct;64(8):1121-7.
3
Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone.
Cancer. 1982 Aug 15;50(4):613-30. doi: 10.1002/1097-0142(19820815)50:4<613::aid-cncr2820500402>3.0.co;2-l.
4
Survival in osteosarcoma in relation to tumor size and location.骨肉瘤患者的生存情况与肿瘤大小和位置的关系。
Clin Orthop Relat Res. 1982 Jul(167):250-4.
5
The prognosis in osteosarcoma: Norwegian National Data.骨肉瘤的预后:挪威国家数据。
Cancer. 1981 Oct 15;48(8):1719-23. doi: 10.1002/1097-0142(19811015)48:8<1719::aid-cncr2820480806>3.0.co;2-j.
6
The unreliability of prognostic criteria in osteosarcoma.骨肉瘤预后标准的不可靠性。
Am J Clin Pathol. 1970 Jan;53(1):15-20. doi: 10.1093/ajcp/53.1.15.
7
Osteogenic sarcoma. Analysis of factors influencing prognosis in 100 cases.骨肉瘤。100例预后影响因素分析。
Clin Orthop Relat Res. 1966 Sep-Oct;48:209-22.
8
Prognosis in osteogenic sarcoma.骨肉瘤的预后
Clin Orthop Relat Res. 1968 May-Jun;58:85-103.
9
Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience.骨肉瘤的术前(新辅助)化疗:十年经验
Orthopedics. 1985 May;8(5):659-64. doi: 10.3928/0147-7447-19850501-19.
10
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.辅助化疗对肢体骨肉瘤患者无复发生存率的影响。
N Engl J Med. 1986 Jun 19;314(25):1600-6. doi: 10.1056/NEJM198606193142502.